Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression

Annals of Oncology

Volumn 15, Issue 10, 2004, Pages 1484-1489

  Montoto, S ^a   Lopez Guillermo A ^a   Altes A ^b   Perea, G ^b   Ferrer, G ^a   Camos M ^a   Villela, L ^b   Bosch, F ^a   Esteve, J ^a   Cervantes, F ^a   Blade J ^a   Nomdedeu, B ^a   Campo, E ^a   Sierra, J ^b   Montserrat, E ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

FLIPI; Follicular lymphoma; Prognosis; Progression

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; HEMOGLOBIN; IFOSFAMIDE; LACTATE DEHYDROGENASE; PREDNISONE; VINCRISTINE;

ADULT; AGE; AGED; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; HISTOPATHOLOGY; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; SYMPTOMATOLOGY;

AGE FACTORS; AGED; DISEASE PROGRESSION; FEMALE; HEALTH STATUS; HUMANS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; SURVIVAL ANALYSIS;

EID: 6944247509     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh406     Document Type: Article

References (30)

1. Horning SJ, Rosenberg SA. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N Engl J Med 1984; 311: 1471-1475.
2. Gallagher CJ, Gregory WM, Jones AE et al. Follicular lymphoma: prognostic factors for response and survival. J Clin Oncol 1986; 4: 1470-1480.
3. Romaguera JE, McLaughlin P, North L et al. Multivariate analysis of prognostic factors in stage IV follicular low-grade lymphoma: a risk model. J Clin Oncol 1991; 9: 762-769.
4. Johnson PW, Rohatiner AZ, Whelan JS et al. Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. J Clin Oncol 1995; 13: 140-147.
5. Friedberg JW, Neuberg D, Stone RM et al. Outcome in patients with myelodysplastic syndrome after autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 1999; 17: 3128-3135.
6. Micallef IN, Lillington DM, Apostolidis J et al. Therapy-related myelodysplasia and secondary acute myelogenous leukemia after high-dose therapy with autologous hematopoietic progenitor-cell support for lymphoid malignancies. J Clin Oncol 2000; 18: 947-955.
7. Hosing C, Munsell M, Yazji S et al. Risk of therapy-related myelodysplastic syndrome/acute leukemia following high-dose therapy and autologous bone marrow transplantation for non-Hodgkin's lymphoma. Ann Oncol 2002; 13: 450-459.
8. Metayer C, Curtis RE, Vose J et al. Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. Blood 2003; 101: 2015-2023.
9. Cabanillas F, Smith T, Bodey GP et al. Nodular malignant lymphomas: factors affecting complete response rate and survival. Cancer 1979; 44: 1983-1989.
10. Cameron DA, Leonard RC, Mao JH, Prescott RJ. Identification of prognostic groups in follicular lymphoma The Scotland and Newcastle Lymphoma Group Therapy Working Party. Leuk Lymphoma 1993; 10: 89-99.
11. Litam P, Swan F, Cabanillas F et al. Prognostic value of serum beta-2 microglobulin in low-grade lymphoma. Ann Intern Med 1991; 114: 855-860.
12. Soubeyran P, Eghbali H, Bonichon F et al. Low-grade follicular lymphomas: analysis of prognosis in a series of 281 patients. Eur J Cancer 1991; 27: 1606-1613.
13. Leonard RC, Hayward RL, Prescott RJ, Wang JX. The identification of discrete prognostic groups in low grade non-Hodgkin's lymphoma The Scotland and Newcastle Lymphoma Group Therapy Working Party. Ann Oncol 1991; 2: 655-662.
14. Federico M, Vitolo U, Zinzani PL et al. Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases Intergruppo Italiano Linfomi. Blood 2000; 95: 783-789.
15. Solal-Céligny PH, Roy P. Follicular lymphoma international prognostic project (FLIPP). Blood 2004; In press.
16. Weisdorf DJ, Andersen JW, Glick JH, Oken MM. Survival after relapse of low-grade non-Hodgkin's lymphoma: implications for marrow transplantation. J Clin Oncol 1992; 10: 942-947.
17. Davidge-Pitts M, Dansey R, Bezwoda WR. Salvage treatment after failure or relapse following initial chemotherapy for follicular non-Hodgkin's lymphoma. Leuk Lymphoma 1997; 24: 341-347.
18. Spinolo JA, Cabanillas F, Dixon DO et al. Therapy of relapsed or refractory low-grade follicular lymphomas: factors associated with complete remission, survival and time to treatment failure. Ann Oncol 1992; 3: 227-232.
19. Montoto S, López-Guillermo A, Ferrer A et al. Survival after progression in patients with follicular lymphoma: analysis of prognostic factors. Ann Oncol 2002; 13: 523-530.
20. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
21. Harris NL, Jaffe ES, Diebold J et al. The World Health Organization classification of neoplasms of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting - Airlie House Virginia, November, 1997. Hematol J 2000; 1: 53-66.
22. Cheson BD, Horning SJ, Coiffier B et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored international Working Group. J Clin Oncol 1999; 17: 1244-1253.
23. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 1993; 329: 987-994.
24. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
25. 2/E in the log-rank test for survival data on tumour incidence data. Biometrics 1973; 29: 759-784.
26. Cox DR. Regression models and life tables. J R Stat Assoc 1972; 34: 187-220.
27. Apostolidis J, Gupta RK, Grenzelias D et al. High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up. J Clin Oncol 2000; 18: 527-536.
28. Brice P, Simon D, Bouabdallah R et al. High-dose therapy with autologous stem-cell transplantation (ASCT) after first progression prolonged survival of follicular lymphoma patients included in the prospective GELF 86 protocol. Ann Oncol 2000; 11: 1585-1590.
29. Stein RS, Greer JP, Goodman S et al. High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin. Bone Marrow Transplant 1999; 23: 227-233.
30. Bierman PJ, Vose JM, Anderson JR et al. High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. J Clin Oncol 1997; 15: 445-450.